These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30232757)

  • 41. Can Gut Microbiota Composition Predict Response to Dietary Treatments?
    Biesiekierski JR; Jalanka J; Staudacher HM
    Nutrients; 2019 May; 11(5):. PubMed ID: 31121812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes.
    Aydin Ö; Nieuwdorp M; Gerdes V
    Curr Diab Rep; 2018 Jun; 18(8):55. PubMed ID: 29931613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy.
    Kang Y; Cai Y
    Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders.
    Ringel Y
    Gastroenterol Clin North Am; 2017 Mar; 46(1):91-101. PubMed ID: 28164856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut microbiome and its role in cardiovascular diseases.
    Ahmadmehrabi S; Tang WHW
    Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
    Brunkwall L; Orho-Melander M
    Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
    Ejtahed HS; Soroush AR; Angoorani P; Larijani B; Hasani-Ranjbar S
    Horm Metab Res; 2016 Jun; 48(6):349-58. PubMed ID: 27203411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. INTESTINAL MICROBIOTA IN DIGESTIVE DISEASES.
    Passos MDCF; Moraes-Filho JP
    Arq Gastroenterol; 2017; 54(3):255-262. PubMed ID: 28723981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between gut microbiota and ethnomedicine constituents.
    Wu XM; Tan RX
    Nat Prod Rep; 2019 May; 36(5):788-809. PubMed ID: 30534698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes, obesity and gut microbiota.
    Everard A; Cani PD
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):73-83. PubMed ID: 23768554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease.
    Wijdeveld M; Nieuwdorp M; IJzerman R
    Expert Opin Ther Targets; 2020 Jul; 24(7):639-653. PubMed ID: 32441559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome.
    Paun A; Danska JS
    Pediatr Diabetes; 2016 Nov; 17(7):469-477. PubMed ID: 27484959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbiota and diabetes: an evolving relationship.
    Tilg H; Moschen AR
    Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of the relationship between the gut microbiota and amino acid metabolism.
    Lin R; Liu W; Piao M; Zhu H
    Amino Acids; 2017 Dec; 49(12):2083-2090. PubMed ID: 28932911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The microbiome: a contributor to health and disease.
    Walker B; Kassim K; Stokes LD
    J Health Care Poor Underserved; 2015 Feb; 26(1):62-72. PubMed ID: 25702727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The human gut microbiome: implications for future health care.
    Kinross JM; von Roon AC; Holmes E; Darzi A; Nicholson JK
    Curr Gastroenterol Rep; 2008 Aug; 10(4):396-403. PubMed ID: 18627653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fecal microbiota transplantation holds the secret to youth.
    Meng Y; Sun J; Zhang G
    Mech Ageing Dev; 2023 Jun; 212():111823. PubMed ID: 37192676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbiome response to diet: focus on obesity and related diseases.
    Delzenne NM; Rodriguez J; Olivares M; Neyrinck AM
    Rev Endocr Metab Disord; 2020 Sep; 21(3):369-380. PubMed ID: 32691288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The gut microbiota in internal medicine: implications for health and disease.
    Lankelma JM; Nieuwdorp M; de Vos WM; Wiersinga WJ
    Neth J Med; 2015 Feb; 73(2):61-8. PubMed ID: 25753070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.